Skip to content

Safety and immune responses after vaccination with two investigational RNA-based vaccines against tuberculosis in healthy volunteers

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509515-89-00
Acronym
BNT164-01
Enrollment
128
Registered
2024-03-13
Start date
2023-04-14
Completion date
2025-12-08
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

None listed

Sponsors

BioNTech SE
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026